These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4201174)

  • 1. The pancreatic beta-cell recognition of insulin secretagogues. Inhibitory effects of a membrane probe on the islet uptake and insulin-releasing action of glibenclamide.
    Hellman B; Lernmark A; Sehlin J; Töljedal IB
    FEBS Lett; 1973 Aug; 34(2):347-9. PubMed ID: 4201174
    [No Abstract]   [Full Text] [Related]  

  • 2. The pancreatic -cell recognition of insulin secretagogues. VII. Binding and permeation of chloromercuribenzene-p-sulphonic acid in the plasma membrane of pancreatic -cells.
    Hellman B; Lernmark A; Sehlin J; Söderberg M; Täljedal IB
    Arch Biochem Biophys; 1973 Sep; 158(1):435-41. PubMed ID: 4199636
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of tolbutamide and glibenclamide on the incorporation of ( 3 H)leucine and on the conversion of proinsulin to insulin in isolated pancreatic islets.
    Schatz H; Maier V; Hinz M; Nierle C; Pfeiffer EF
    FEBS Lett; 1972 Oct; 26(1):237-40. PubMed ID: 4629118
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatic islet uptake of sucrose and urea in the absence and presence of glucose.
    Lernmark A; Sehlin J; Täljedal IB
    Horm Res; 1974; 5(3):182-6. PubMed ID: 4599420
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors affecting the uptake of glibenclamide in microdissected pancreatic islets rich in beta-cells.
    Hellman B
    Pharmacology; 1974; 11(5):257-67. PubMed ID: 4212009
    [No Abstract]   [Full Text] [Related]  

  • 6. Uptake of glibornuride by microdissected pancreatic islets.
    Täljedal IB
    Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation and inhibition of insulin release by an amino-reactive probe of plasma membrane.
    Hellman B; Idahl LA; Lernmark A; Sehlin J; Täljedal IB
    J Membr Biol; 1973 Dec; 14(2):135-42. PubMed ID: 4590247
    [No Abstract]   [Full Text] [Related]  

  • 8. Glibenclamide inhibits islet carnitine palmitoyltransferase 1 activity, leading to PKC-dependent insulin exocytosis.
    Lehtihet M; Welsh N; Berggren PO; Cook GA; Sjoholm A
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E438-46. PubMed ID: 12684219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pancreatic beta-cell recognition of insulin secretagogues. Comparisons of glucose with glyceraldehyde isomers and dihydroxyacetone.
    Hellman B; Idahl LA; Lernmark A; Sehlin J; Täljedal IB
    Arch Biochem Biophys; 1974 Jun; 162(2):448-57. PubMed ID: 4210076
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.
    Fuhlendorff J; Rorsman P; Kofod H; Brand CL; Rolin B; MacKay P; Shymko R; Carr RD
    Diabetes; 1998 Mar; 47(3):345-51. PubMed ID: 9519738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pancreatic beta-cell recognition of insulin secretagogues. Effects of calcium and sodium on glucose metabolism and insulin release.
    Hellman B; Idahl LA; Lernmark A; Sehlin J; Täljedal IB
    Biochem J; 1974 Jan; 138(1):33-45. PubMed ID: 4601168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodoacetamide-induced sensitization of the pancreatic beta-cells to glucose stimulation.
    Hellman B; Idahl LA; Lernmark A; Sehlin J; Täljedal IB
    Biochem J; 1973 Apr; 132(4):775-89. PubMed ID: 4198516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pancreatic beta-cell recognition of insulin secretagogues. XIII. Effects of sulphydryl reagents on cyclic AMP.
    Hellman B; Idahl LA; Lernmark A; Täljedal IB
    Biochim Biophys Acta; 1974 Nov; 372(1):127-34. PubMed ID: 4371860
    [No Abstract]   [Full Text] [Related]  

  • 14. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
    Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
    Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the possible role of thiol groups in the insulin-releasing action of mercurials, organic disulfides, alkylating agents, and sulfonylureas.
    Hellman B; Lernmark A; Sehlin J; Söderberg M; Täljedal IB
    Endocrinology; 1976 Nov; 99(5):1398-406. PubMed ID: 186256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of glibenclamide on rat islet radioactive nucleotide efflux, ATP contents and respiratory rates.
    Welsh M
    Biochem Pharmacol; 1983 Oct; 32(19):2903-8. PubMed ID: 6414483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of sulfonylureas with pancreatic beta-cells. A study with glyburide.
    Gorus FK; Schuit FC; In't Veld PA; Gepts W; Pipeleers DG
    Diabetes; 1988 Aug; 37(8):1090-5. PubMed ID: 2839387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of the stimulatory effects of efaroxan and glibenclamide in rat pancreatic islets by the imidazoline, RX801080.
    Brown CA; Chan SL; Stillings MR; Smith SA; Morgan NG
    Br J Pharmacol; 1993 Nov; 110(3):1017-22. PubMed ID: 7905338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals.
    Dunbar JC; Foà PP
    Diabetologia; 1974 Feb; 10(1):27-35. PubMed ID: 4209518
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term actions of sulfonylureas on (pro-) insulin biosynthesis and secretion: I. Lack of evidence for a compensatory increase in (pro-) insulin biosynthesis after exposure of isolated pancreatic rat islets to tolbutamide and glibenclamide in vitro.
    Schatz H; Steinle D; Pfeiffer EF
    Horm Metab Res; 1977 Nov; 9(6):457-65. PubMed ID: 412764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.